Legend Biotech (LEGN) Gains from Sales and Divestitures (2020 - 2025)
Legend Biotech (LEGN) recorded Gains from Sales and Divestitures of $197,000 in Q2 2025, up 271.7% from the prior quarter.
Powered by 
Analysis
Legend Biotech (LEGN) Gains from Sales and Divestitures (2020 - 2025) Analysis & Trends
On a TTM basis, Legend Biotech's Gains from Sales and Divestitures came in at $250,000 as of Jun 30, 2025, up 187.4% year-over-year; for FY2024, it was $2,000, down 99.1% from FY2023.
- Annual Gains from Sales and Divestitures has declined for three straight years, with a four-year compound annual growth rate of -56.3% (FY2020 to FY2024).
- Across earlier years, Gains from Sales and Divestitures came in at $226,000 in FY2023 (-53.0%), $481,000 in FY2022 (-50.6%), $974,000 in FY2021 and $55,000 in FY2020.
- The Q2 2025 figure is the highest quarterly Gains from Sales and Divestitures since Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Legend Biotech | 3.42 Bn | -317.56 Mn | 251.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 197,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 82,000.00 |
| Jun 30, 2023 | 66,000.00 |
| Mar 31, 2023 | 75,000.00 |
| Dec 31, 2022 | 473,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Mar 31, 2022 | 20,000.00 |
| Dec 31, 2021 | -3,000.00 |
| Sep 30, 2021 | 40,000.00 |
| Jun 30, 2021 | 883,000.00 |
| Mar 31, 2021 | 54,000.00 |
| Dec 31, 2020 | 44,000.00 |
| Sep 30, 2020 | 10,000.00 |
API Access
Legend Biotech Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=LEGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "LEGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=LEGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();